McKenna Mark C. 4
4 · Apogee Therapeutics, Inc. · Filed Aug 21, 2023
Insider Transaction Report
Form 4
McKenna Mark C.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-08-17+50,000→ 50,000 totalExercise: $23.60Exp: 2033-08-17→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-17+100,000→ 150,000 totalExercise: $23.60Exp: 2033-08-17→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]This option represents the right to purchase 50,000 shares of the Issuer's common stock, which will vest in thirty-six equal monthly installments over a three-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents the right to purchase 100,000 shares of the Issuer's common stock, which will vest in thirty-six equal monthly installments over a three-year period from the date of grant, contingent upon approval of the option at the Issuer's 2024 Annual Meeting of Stockholders and subject to the Reporting Person's continued service to the Issuer.